Overview

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the efficacy of pioglitazone compared to glibenclamide, once daily (QD), taken together with metformin and lifestyle modification in type 2 diabetic subjects with cardiovascular disease.

Phase:

Phase 4

Details

Lead Sponsor:

Takeda

Treatments:

Glyburide
Metformin
Pioglitazone